Metabolism
Metabolism inhibitors are compounds that interfere with metabolic pathways, altering the production and utilization of energy within cells. These inhibitors are used to study the regulation of metabolism, the role of metabolic pathways in diseases like cancer and diabetes, and to develop new therapeutic strategies. Metabolism inhibitors can target various enzymes and processes involved in glycolysis, fatty acid oxidation, and other metabolic functions. At CymitQuimica, we offer a wide range of high-quality metabolism inhibitors to support your research in biochemistry, metabolic disorders, and drug development.
Subcategories of "Metabolism"
- AhR(42 products)
- Aminopeptidase(76 products)
- CETP(20 products)
- Carbonic Anhydrase(195 products)
- Casein Kinase(137 products)
- DHFR(34 products)
- Decarboxylase(4 products)
- Dehydrogenase(302 products)
- FAAH(66 products)
- FXR(62 products)
- Factor Xa(87 products)
- Fatty Acid Synthase(37 products)
- Ferroptosis(226 products)
- GR(3 products)
- GSNOR(4 products)
- Glucokinase(57 products)
- HIF/HIF Prolyl-Hydroxylase(146 products)
- HMG-CoA Reductase(33 products)
- Hydroxylase(35 products)
- IDO(84 products)
- LDL(8 products)
- Lipase(107 products)
- Lipid(61 products)
- Lipoxygenase(134 products)
- MAO(87 products)
- MPO(2 products)
- NAMPT(40 products)
- P450(6 products)
- PAI-1(26 products)
- PDE(167 products)
- PED(1 products)
- PKM(17 products)
- PPAR(169 products)
- Phospholipase(83 products)
- ROR(47 products)
- Retinoid Receptor(28 products)
- SGK(11 products)
- Thioredoxin(12 products)
- Transferase(29 products)
- Transporter(46 products)
- UGT(4 products)
- Xanthine Oxidase (XO) Inhibitors(9 products)
Show 34 more subcategories
Found 9275 products of "Metabolism"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ro 31-8472
CAS:Ro 31-8472 is an angiotensin-converting enzyme (ACE) inhibitor and an analog of cilazaprilat.Formula:C20H27N3O6Purity:98%Color and Shape:SolidMolecular weight:405.44Dioctanoylphosphatidic acid sodium
CAS:Dioctanoylphosphatidic acid sodium serves as a modulator of phagocyte respiratory bursts, a precursor to diacylglycerol and lyso-phosphatidic acid, and influences the phosphorylation of the mammalian target of rapamycin (mTOR). Additionally, it enhances the viability of gallbladder cancer cells inhibited by histone deacetylase inhibitors (HDACI). This compound is derived from glycerophospholipids through the action of phospholipase D.Formula:C19H36NaO8PColor and Shape:SolidMolecular weight:446.45Carbonic anhydrase inhibitor 19
CAS:Carbonic anhydrase inhibitor19 (compound 26a) targets glaucoma-associated isozymes hCA II and hCA XII, with inhibition constants (Kis) of 9.4 nM and 6.7 nM, respectively. This compound is effective in reducing intraocular pressure.Formula:C23H25N3O6S2Molecular weight:503.59α-Amylase-IN-7
CAS:α-Amylase-IN-7 (Compound 6e) is an inhibitor of α-Amylase, with an IC50 of 40 μM, indicating its potency. This compound shows potential as an anti-diabetic medication.Formula:C18H15ClN6O2SMolecular weight:414.879-cis-β-Carotene
CAS:9-cis-β-Carotene, a precursor of retinal, is cleaved by beta-carotene oxygenase 1 (BCMO1) to produce 9-cis-retinal.Formula:C40H56Purity:98%Color and Shape:SolidMolecular weight:536.87HSD17B13-IN-17
CAS:HSD17B13-IN-17 (compound 9) serves as a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13). It demonstrates inhibitory efficacy with IC50 values of ＜0.1 μM for estradiol and ＜1 μM for Leukotriene B3 as substrates. This compound is significant in the management of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH) [1].Formula:C20H16ClFN2O3SMolecular weight:418.87SCO-792
SCO-792: potent, reversible oral enteropeptidase inhibitor, with slow in vitro dissociation and in vivo protein digestion blocking.Formula:C22H22N4O8·xH2OColor and Shape:Solid3-Oxochenodeoxycholic acid
CAS:3-Oxochenodeoxycholic acid is an endogenous metabolite detectable in feces and may serve as a diagnostic marker for various diseases, including COVID-19.Formula:C24H38O4Molecular weight:390.556N-Boc-3-hydroxy-1,2,3,6-tetrahydropyridine
CAS:N-Boc-3-hydroxy-1,2,3,6-tetrahydropyridine enhances β-glucocerebrosidase (β-Glucocerebrosidase) activity by 20%. It is used in research on lysosomal storage disorders and other protein accumulation diseases.Formula:C10H17NO3Color and Shape:SolidMolecular weight:199.25Complex III-IN-2
Complex III-IN-2 inhibits complex III, with antifungal EC50: 29.31 mg/L vs R. solani, 29.98 mg/L vs S. sclerotiorum.Formula:C15H21ClN2O2SColor and Shape:SolidMolecular weight:328.86SGK1-IN-3
SGK1-IN-3: Potent oral inhibitor of SGK1, may target osteoarthritis.Formula:C23H20Cl2N6O3SColor and Shape:SolidMolecular weight:531.41NRMA-8
CAS:NRMA-8 is a small-molecule nuclear receptor modulator capable of penetrating the brain. It holds potential for research into central nervous system (CNS) diseases, including Alzheimer's disease, Parkinson's disease, demyelinating diseases, and glioblastoma.Formula:C20H23ClN2O3Color and Shape:SolidMolecular weight:374.8615-epi-PGE1
CAS:15-epi-PGE1 (15R-Prostaglandin E1; 15-Epiprostaglandin E1), a stereoisomer of PGE1, exhibits reduced biological activity [2]. This compound acts as a non-competitive inhibitor of human placental 15-Hydroxyprostaglandin dehydrogenase (15-PGDH), with an inhibitory concentration 50 (IC50) value of 170 μM [1].Formula:C20H34O5Molecular weight:354.48CIT-ALD
CAS:CIT-ALD is an aldehyde intermediate formed during the metabolism of Citalopram. It has potential applications in the research of neurological disorders.Formula:C18H14FNO2Molecular weight:295.31Human enteropeptidase-IN-2
Human enteropeptidase-IN-2 is a potent inhibitor of enteropeptidase (enteropeptidase) and can be used in anti-obesity studies.Formula:C20H19F3N4O7Color and Shape:SolidMolecular weight:484.38PDE5-IN-8
CAS:PDE5-IN-8 (compound 2) is an inhibitor of PDEs.Formula:C22H20ClN3O2Color and Shape:SolidMolecular weight:393.87BAY-179
CAS:BAY-179 is a potent, selective, species cross-reactive complex I inhibitor for the study of cancer.Formula:C23H21N5OSPurity:98.29%Color and Shape:SolidMolecular weight:415.51A-800141
CAS:A-800141 is an orally active and selective MetAP2 inhibitor with an IC50 of 12 nM, while showing weaker inhibitory activity against MetAP1 (IC50: 36 μM). GAPDH can serve as a biomarker for monitoring the inhibition of MetAP2 by A-800141. This compound exhibits anti-angiogenic and anticancer properties in various xenograft tumor models.Formula:C24H30N2O4SColor and Shape:SolidMolecular weight:442.571Anticancer agent 142
CAS:Compound 142 (also known as Compound 235) is a PTPN inhibitor with potential applications in cancer research [1].Formula:C13H14BrF2N2O7PS2Purity:98%Color and Shape:SolidMolecular weight:523.26SCP1-IN-2
SCP1-IN-2: potent, selective SCP1 inhibitor; induces REST degradation, hinders its activity, may study REST-driven glioblastoma growth.Formula:C19H17F3N2O6S2Color and Shape:SolidMolecular weight:490.47
